雜志介紹

Current Gene Therapy雜志介紹

《Current Gene Therapy》是一本以English為主的未開放獲取國際優秀期刊，中文名稱當前的基因治療，本刊主要出版、報道醫學-GENETICS & HEREDITY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為3.8，最新CiteScore 指數為6.7。

本刊近期中國學者發表的論文主要有：

• Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer.

  Author: Wang Q¹, Yang M¹, Zhang Y², Zhong L³, Zheng X¹.

• Gene Therapy on the Road

  Author: Feng YM¹.

• Novel p53 delivery systems in the treatment of head and neck cancer.

  Author: Lu Y¹, Wang H¹.

• Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems.

  Author: Ding B, Li T, Zhang J, Zhao L, Zhai G.

英文介紹

Current Gene Therapy雜志英文介紹

Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.

Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.